Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial

Clicks: 355
ID: 112585
1994
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Ribavirin aerosol therapy can be safely administered to mechanically ventilated children with severe respiratory syncytial virus lower respiratory tract disease. However, this therapy does not appear to affect immediate clinical outcome in such patients.
Reference Key
kl1994criticalaerosolized Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Meert KL;Sarnaik AP;Gelmini MJ;Lieh-Lai MW;;
Journal critical care medicine
Year 1994
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8143465
Keywords
respiration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Infant Prospective Studies Clinical Trial Randomized Controlled Trial Double-Blind Method Artificial intensive care units aerosols respiratory syncytial virus infections / drug therapy* pmid:8143465 doi:10.1097/00003246-199404000-00010 k l meert a p sarnaik m w lieh-lai pediatric respiratory syncytial virus infections / physiopathology ribavirin / administration & dosage*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.